Y-mAbs Therapeutics Stock (NASDAQ: YMAB) stock price, news, charts, stock research, profile.
Open | $13.99 |
Close | $13.73 |
Volume / Avg. | 1.11M / 279.83K |
Day Range | $13.63 - $14.33 |
52 Wk Range | 4.69 - 20.90 |
Market Cap | $611.94M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 11.29% |
Days to Cover | 11.91 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Y-mAbs Therapeutics (NASDAQ:YMAB) through any online brokerage.
Other companies in Y-mAbs Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), 4D Molecular Therapeutics (NASDAQ:FDMT), Celcuity (NASDAQ:CELC), Replimune Group (NASDAQ:REPL) and Mesoblast (NASDAQ:MESO).
Y-mAbs Therapeutics has a consensus price target of $19.17.
The stock price for Y-mAbs Therapeutics (NASDAQ: YMAB) is $13.73 last updated September 20, 2024 at 4:02 PM EDT.
There are no upcoming dividends for Y-mAbs Therapeutics.
Y-mAbs Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Y-mAbs Therapeutics.
Y-mAbs Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.